(PROG), CYTOSORBENTS COR (CTSO) - CytoSorbents, Progenity Receive Funding For Product Development benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Date Time
Researchers discover new class of cancer fighting compounds
CORVALLIS, Ore. – A team of Oregon State University scientists has discovered a new class of anti-cancer compounds that effectively kill liver and breast cancer cells.
The findings, recently published in the journal Apoptosis, describe the discovery and characterization of compounds, designated as Select Modulators of AhR-regulated Transcription (SMAhRTs).
Edmond Francis O’Donnell III and a team of OSU researchers conducted the research in the laboratory of Siva Kolluri, a professor of cancer research at Oregon State. They also identified the aryl hydrocarbon receptor (AhR) as a new molecular target for development of cancer therapeutics.
TORONTO In the middle of the COVID-19 pandemic, researchers in Saskatoon are suiting up for another fight. Theyâre part of a worldwide effort to create what could be a holy grail: a universal vaccine that might be able to work against all future coronavirus-related viruses. Itâs like fire insurance, Volker Gerdts, director and CEO of the Vaccine and Infectious Disease Organization at the University of Saskatchewan, told CTV News. âHopefully you will never use it. Hopefully you wasted that money,â Gerdts said. âBut when you have a fire, when a new disease breaks out, you re ready, and that s the concept for this.â
Argonne s Advanced Photon Source guided the development of new COVID-19 vaccine now in trials
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE s Argonne National Laboratory, and other light sources.
Trials are taking place at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command, following up on early tests that showed promising results.
Argonne s Advanced Photon Source plays pivotal role in new COVID-19 vaccine now in trials eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.